Since the DNA methyltransferase inhibitor 5-Aza-CdR can reactivate tumor suppressor genes silenced by promoter methylation, we examined whether it could upregulate ESRP1 expression in RCC cells. The gene discussed is ESRP1; the disease is renal cell carcinoma.